FDA gives fast-track designation to Arca biopharma’s COVID treatment
WESTMINSTER — A potential therapy for severe COVID-19 patients being developed by Arca Biopharma Inc. (Nasdaq: ARCA) received a fast-track […]
Source: BizWest
Check out market updates
WESTMINSTER — A potential therapy for severe COVID-19 patients being developed by Arca Biopharma Inc. (Nasdaq: ARCA) received a fast-track […]
Source: BizWest